Candidate for treatment with trastuzumab. Prior treatment with trastuzumab and or/ lapatinib in the neoadjuvant, adjuvant or metastatic disease setting is permitted. Treatment with hormone therapy in the adjuvant and/or advanced disease setting is permitted. [clinicaltrials_resource:f1812e7dd1d0c7ae8443365028e63b13]

Candidate for treatment with trastuzumab. Prior treatment with trastuzumab and or/ lapatinib in the neoadjuvant, adjuvant or metastatic disease setting is permitted. Treatment with hormone therapy in the adjuvant and/or advanced disease setting is permitted. [clinicaltrials_resource:f1812e7dd1d0c7ae8443365028e63b13]

Inclusion Criteria [clinicaltrials_vocabulary:Inclusion-Criteria]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:f1812e7dd1d0c7ae8443365028e63b13

Candidate for treatment with trastuzumab. Prior treatment with trastuzumab and or/ lapatinib in the neoadjuvant, adjuvant or metastatic disease setting is permitted. Treatment with hormone therapy in the adjuvant and/or advanced disease setting is permitted. [clinicaltrials_resource:f1812e7dd1d0c7ae8443365028e63b13]

Inclusion Criteria [clinicaltrials_vocabulary:Inclusion-Criteria]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:f1812e7dd1d0c7ae8443365028e63b13
Bio2RDF identifier
f1812e7dd1d0c7ae8443365028e63b13
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f1812e7dd1d0c7ae8443365028e63b13
identifier
clinicaltrials_resource:f1812e7dd1d0c7ae8443365028e63b13
title
Candidate for treatment with t ...... ing is permitted.
@en
inDataset
type
label
Candidate for treatment with t ...... 12e7dd1d0c7ae8443365028e63b13]
@en